ArticleJTO clinical and research reports2022

Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report.

Yoshinari Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.